This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Oncolytic Viruses / Non-viral Gene Therapy Delivery
November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Victor Cervera-Carrascón
Vice President of Business Development at TILT Biotherapeutics, Finland
Speaker

Agenda Sessions

  • Emerging Results with a Cytokine Armed Oncolytic Adenovirus Designed to Enable T-cell Responses

    , 11:20am
    View Session

At this event

Prev
Next
Tony De Fougerolles
CEO
Evox Therapeutics Limited

See Victor at Oncolytic Viruses / Non-viral Gene Therapy Delivery